Effect of atorvastatin and genfibrozile on C reactive protein and inflammatory cytokines in dyslipidemic patients with and without coronary artery disease

被引:0
|
作者
Jaramillo, PL
Cubillos, LA
Casas, JP
Silva, F
Oubiña, MP
Cachofeiro, V
Lahera, V
机构
[1] UCM, Sch Med, Dept Physiol, Madrid, Spain
[2] F Cardiovasc Oriente Colombiano, Bucaramanga, Colombia
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:S270 / S271
页数:2
相关论文
共 50 条
  • [1] Effect of atorvastatin and gemfibrozil on inflammatory markers in dyslipidemic patients with and without coronary artery disease
    Jaramillo, PL
    Cubillos, L
    Casas, J
    Silva, F
    Oubiña, M
    Cachofeiro, V
    Lahera, V
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 11 - 11
  • [2] The effect of simvastatin on C-reactive protein in dyslipidemic patients with or without coronary artery disease
    Karagkiozaki, V
    Borghi, L
    Litsas, I
    Gotsis, A
    Terzi, S
    Passalidou, M
    Kerameas, N
    Karali, A
    Risggits, A
    Koutsogiannis, O
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 128 - 128
  • [3] The effect of simvastatin on C-reactive protein in dyslipidemic hypertensives with or without coronary artery disease
    Karagkiozaki, V
    Borghi, L
    Koukoutsis, I
    Passalidou, M
    Litsas, I
    Terzi, S
    Gotsis, A
    Tsaraktsidou, T
    Koutsogiannis, O
    JOURNAL OF HYPERTENSION, 2004, 22 : S390 - S390
  • [4] Inflammatory markers in dyslipidemic patients with and without coronary artery disease. Effect of hypolipidemic treatment
    Lopez-Jaramillo, P
    Cubillos, LA
    Casas, JP
    Silva, F
    Oubina, MP
    Cachofeiro, V
    Lahera, V
    JOURNAL OF HYPERTENSION, 2004, 22 : S104 - S104
  • [5] Atorvastatin affects C-reactive protein levels in patients with coronary artery disease
    Karaca, I
    Ilkay, E
    Akbulut, M
    Yavuzkir, M
    Pekdemir, M
    Akbulut, H
    Arslan, N
    CURRENT MEDICAL RESEARCH AND OPINION, 2003, 19 (03) : 187 - 191
  • [6] Effect of statins on C-reactive protein in patients with coronary artery disease
    Strandberg, TE
    Vanhanen, H
    Tikkanen, MJ
    LANCET, 1999, 353 (9147): : 118 - 119
  • [7] Decrease in C-reactive protein level by atorvastatin treatment in population with coronary artery disease
    Karaca, I
    Akbulut, M
    Kilicoglu, AE
    Ilkay, E
    Pekdemir, M
    Ozbay, Y
    Arslan, N
    ADVANCES IN CORONARY ARTERY DISEASE, 2001, : 217 - 221
  • [8] Reciprocal production of adiponectin and C-reactive protein in coronary circulation of patients with and without coronary artery disease
    Kawagoe, J.
    Imamura, T.
    Date, H.
    Ideguchi, T.
    Koyama, S.
    Nagoshi, Y.
    Tatsumoto, M.
    Onitsuka, H.
    Iwakiri, H.
    Kitamura, K.
    HORMONE AND METABOLIC RESEARCH, 2008, 40 (08) : 578 - 580
  • [9] MONOMERIC C-REACTIVE PROTEIN AND LOCAL INFLAMMATORY RESPONSE IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
    Melnikov, I.
    Chumachenko, P.
    Kozlov, S.
    Majorova, A.
    Saburova, O.
    Portnaya, T.
    Osidak, M.
    Domogatsky, S.
    Buryachkovskaya, L.
    Gabbasov, Z.
    ATHEROSCLEROSIS, 2018, 275 : E105 - E105
  • [10] Apolipoprotein E polymorphism in Omani dyslipidemic patients with and without coronary artery disease
    Al-Yahyaee, Said Ali S.
    Ganguly, Shyam Sundar
    Al-Kindi, Mohammed Nasser
    Al-Bahrani, Ali Ihassan
    HUMAN BIOLOGY, 2007, 79 (01) : 93 - 102